Nature Search

Predictive models of melanoma metastasis based on dermatoscopy in an international retrospective human reader study

Dermatoscopy is a common method to aid in diagnosis of melanoma, however, its utility in predicting metastasis is not fully known. Here, the authors leverage a cohort of 30 dermatologists to develop models to predict prognosis from dermatoscopic images.

Konstantinos Lallas
Harald Kittler
Aimilios Lallas
ResearchOpen Access08 Dec 2025
Nature Communications

Volume: 16, P: 1-12
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance

Myelomagenesis progresses through well-defined pre-malignant states. Here, using single-cell RNA sequencing and T cell receptor repertoire analysis of bone marrow T cells in patients at different stages of myelomagenesis, the authors identify large clonotypic expansions characterized by the expression of multiple immune checkpoints.

Cirino Botta
Cristina Perez
Bruno Paiva
ResearchOpen Access20 Sept 2023
Nature Communications

Volume: 14, P: 1-15
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report

David L. Murray
Noemi Puig
Brian Durie
ResearchOpen Access01 Feb 2021
Blood Cancer Journal

Volume: 11, P: 1-6
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis

Giovanni Palladini
Bruno Paiva
Giampaolo Merlini
ResearchOpen Access16 Feb 2021
Blood Cancer Journal

Volume: 11, P: 1-7
Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature

Paula Rodríguez-Otero
María Victoria Mateos
Jesús F. San Miguel
ResearchOpen Access18 Mar 2019
Blood Cancer Journal

Volume: 9, P: 1-6
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis

Noemi Puig
Bruno Paiva
Jesús F. San Miguel
Research12 Dec 2018
Leukemia

Volume: 33, P: 1256-1267
Hypoalbuminemia: a new risk factor for progression in patients with monoclonal gammopathy of uncertain significance

Elena Alejo
Verónica González-Calle
María-Victoria Mateos
ResearchOpen Access24 Oct 2025
Blood Cancer Journal

Volume: 15, P: 1-8
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia

Irene Dogliotti
Cristina Jiménez
Ramón García-Sanz
ResearchOpen Access26 Nov 2022
Leukemia

Volume: 37, P: 388-395
Opportunities and challenges for MRD assessment in the clinical management of multiple myeloma

Multiple myeloma is a malignancy at the forefront of measurable residual disease (MRD) assessment. In this Review, the authors describe the evolution of MRD analysis in multiple myeloma from technical and clinical standpoints, and discuss opportunities and challenges for MRD-guided management of this disease.

Bruno Paiva
Qian Shi
Jesús San-Miguel
Reviews07 Apr 2025
Nature Reviews Clinical Oncology

Volume: 22, P: 424-438
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

José-Manuel Casas-Rojo
Juan-Miguel Antón-Santos
Hector Meijide Míguez
ResearchOpen Access18 Oct 2023
Scientific Reports

Volume: 13, P: 1-18
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis

Isabel Cuenca
Daniel Alameda
Joaquin Martinez-Lopez
ResearchOpen Access19 Mar 2020
Leukemia

Volume: 35, P: 245-249
Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry

Crhistian-Mario Oblitas
Pablo Demelo-Rodríguez
Hector Meijide Míguez
ResearchOpen Access05 Mar 2025
Scientific Reports

Volume: 15, P: 1-13
Multiple myeloma with t(11;14): impact of novel agents on outcome

Borja Puertas
Verónica González-Calle
María-Victoria Mateos
ResearchOpen Access20 Mar 2023
Blood Cancer Journal

Volume: 13, P: 1-8
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial

Noemi Puig
Miguel T. Hernández
María-Victoria Mateos
ResearchOpen Access21 May 2021
Blood Cancer Journal

Volume: 11, P: 1-11
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

Alejandro Medina
Noemi Puig
Ramon Garcia-Sanz
ResearchOpen Access30 Oct 2020
Blood Cancer Journal

Volume: 10, P: 1-10
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma

Juan-José Garcés
Gabriel Bretones
Bruno Paiva
Research01 Jun 2020
Leukemia

Volume: 34, P: 3007-3018
Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

María García-Álvarez
Sara Alonso-Álvarez
Miguel Alcoceba
ResearchOpen Access17 Jun 2019
Blood Cancer Journal

Volume: 9, P: 1-10
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

Alejandro Medina
Cristina Jiménez
Ramón García-Sanz
ResearchOpen Access06 Feb 2020
Blood Cancer Journal

Volume: 10, P: 1-12
Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role

Paula Rodríguez-Otero
María Victoria Mateos
Jesús F. San Miguel
Research23 Feb 2018
Leukemia

Volume: 32, P: 2427-2434
Genetic complexity impacts the clinical outcome of follicular lymphoma patients

María García-Álvarez
Sara Alonso-Álvarez
Miguel Alcoceba
CorrespondenceOpen Access11 Jan 2021
Blood Cancer Journal

Volume: 11, P: 1-4
Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role

Paula Rodríguez-Otero
María Victoria Mateos
Jesús F. San Miguel
Amendments and Corrections08 Mar 2019
Leukemia

Volume: 33, P: 1056
Predictors of clinically significant quality of life impairment in Parkinson’s disease

Diego Santos García
Teresa de Deus Fonticoba
María D. Villar
ResearchOpen Access16 Dec 2021
npj Parkinson's Disease

Volume: 7, P: 1-10

Search

Predictive models of melanoma metastasis based on dermatoscopy in an international retrospective human reader study

Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance

Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report

Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis

Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature

Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis

Hypoalbuminemia: a new risk factor for progression in patients with monoclonal gammopathy of uncertain significance

Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia

Opportunities and challenges for MRD assessment in the clinical management of multiple myeloma

Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis

Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry

Multiple myeloma with t(11;14): impact of novel agents on outcome

Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma

Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role

Genetic complexity impacts the clinical outcome of follicular lymphoma patients

Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role

Predictors of clinically significant quality of life impairment in Parkinson’s disease

Search

Quick links

Search

Filter By:

Search

Quick links